Meeting
2023 ASCO Annual Meeting
Personalized therapy for head and neck squamous carcinoma (HNSCC) utilizing tissue proteomics profiling.
Authors
Sheeno P. Thyparambil
mProbe Inc., Rockville, MD
Sheeno P. Thyparambil , Wei-Li Liao , Amanda Strasbaugh , Marya Abebe Melkie , Negin Ghafourian , Robert Heaton , Xuefeng Ling
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Advanced/Metastatic Disease
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 6045)
DOI
10.1200/JCO.2023.41.16_suppl.6045
Abstract #
6045
Poster Bd #
37
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Unveiling proteomic diversity: A quantitative study of antibody drug conjugate and chemotherapy targets in gastroesophageal cancer.
First Author: Sheeno P. Thyparambil
Poster
2020 ASCO Virtual Scientific Program
Proteomic profiling to identify therapeutics targets in glioblastoma (GBM).
First Author: Sheeno P. Thyparambil
First Author: Rebecca Feldman
Poster
2014 ASCO Annual Meeting
Molecular profiling of 6,892 colorectal cancer patients to identify potential treatment options.
First Author: Wafik S. El-Deiry